TP53 and non-small cell lung carcinoma: The results of protein interaction network combined with enrichment analysis were used to obtain nobiletin, a key compound of Citrus aurantium for the treatment of NSCLC, and five key targets: TP53, CXCL8, ESR1, PPAR-α, and MMP9.